4BASEBIO PLC Logo

4BASEBIO PLC

Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.

4BB | IL

Overview

Corporate Details

ISIN(s):
GB00BMCLYF79
LEI:
213800E2DX9EAIUNCB30
Country:
United Kingdom
Address:
25 NORMAN WAY, CB24 5QE CAMBRIDGESHIRE

Description

4BASEBIO PLC is a biotechnology company specializing in the design and manufacturing of synthetic DNA for next-generation therapeutics and vaccines. The company provides high-purity, Good Manufacturing Practice (GMP) grade nucleic acid products, including its proprietary opDNA®, as a plasmid-free alternative to traditional methods. Its technology is engineered to accelerate development timelines, enhance safety, and improve manufacturing scalability for applications in genetic medicine, including mRNA vaccines, viral vector-based gene therapies, and gene editing. 4basebio's solutions aim to eliminate production bottlenecks and de-risk manufacturing for partners in the pharmaceutical and biotechnology sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-09-09 08:00
4basebio Plc - Update re Equity Issuance, Secondary Sale and the board
English 45.4 KB
2024-08-08 16:37
4basebio Plc - Strategic Advisory Board & Appointment of Director
English 22.5 KB
2024-07-29 17:31
4basebio Plc - £40.0m Equity Issuance and £29.4m Secondary Sale
English 22.0 KB
2024-07-18 08:00
4basebio Plc - Employee Long Term Incentive Plan and Issue of Equity
English 21.1 KB
2024-06-28 16:45
4basebio Plc - Result of AGM
English 9.2 KB
2024-06-11 15:42
4basebio Plc - Holding(s) in Company
English 37.8 KB
2024-06-11 08:00
4basebio Plc - Holding(s) in Company
English 41.6 KB
2024-06-05 08:00
4basebio Plc - Final Results and Notice of AGM
English 211.8 KB
2024-05-30 16:30
4basebio Plc - Holding(s) in Company
English 40.0 KB
2024-04-10 08:00
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Ti…
English 10.6 KB
2024-03-21 08:00
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA …
English 12.3 KB
2024-03-01 08:00
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthe…
English 15.6 KB
2024-02-06 08:01
4basebio Plc - Holding(s) in Company
English 38.0 KB
2024-02-06 08:00
4basebio Plc - Exercise of Options
English 8.7 KB
2024-02-05 08:01
4basebio Plc - Holding(s) in Company
English 38.2 KB

Automate Your Workflow. Get a real-time feed of all 4BASEBIO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 4BASEBIO PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 4BASEBIO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD
Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.